CORE team
Our Team has a rich history of engagement with some of the world's most interesting, diverse, and specialized organizations.
Scott P. Bruder, MD, PhD
Founder & CEO
James M. Petricek, MSE, MBA
Vice President
Susan Drapeau, PhD
Vice President
Kristen D. Allen, RAC
Engagement Partner
Quality & Regulatory AffaIrs
Strategy & Submissions
Spencer B. Bailey, MBA, CPC
Engagement Partner
Reimbursement &
Health Economics
Lisa M. Bruder, MEd
Artistic Director
& Logistics
Chris Fair
Engagement Partner
Business Development
& Diligence
Roger Harrington, PhD
Engagement Partner
Biomanufacturing &
Process Development
Philip Lavin, PhD, FASA, FRAPS
Engagement Partner
Biostatistics & Regulatory, Clinical, Commercial Strategy
Rebecca Marshall, MS, MBA
Engagement Partner
Strategic Planning &
Market Development
Gloria Polito
Executive Adminstrative
Assistant
Patrick Reischling, MBS
Engagement Partner
Clinical Affairs and Strategy
Laura Rose, PhD
Engagement Partner
Regulatory Affairs
Strategy & Submissions
Nicola Selley
Engagement Partner
Regulatory Affairs
Strategy & Submissions
Conan Young, PhD
Engagement Partner
Preclinical & Product Development
Charlie Boy, DOG
Canis Associate
Nilla Wafer, DOG
Chief Canine Officer, Emeritus
special advisors
In relevant disciplines, we collaborate with world-leading academic investigators and clinicians to provide you additional perspectives.
Roy K. Aaron, MD
Orthopaedic Surgery &
Translational Research
Arnold I. Caplan, PhD
Cell Therapy &
Biologics
Steven A. Goldstein, PhD
Biomedical Engineering
& Orthopaedics
Wellington K. Hsu, MD
Spine Surgery &
Preclinical Research
Andrew J. Nelson, MD
Orthopaedic Surgery
& Diligence
W.R. (Bill) Walsh, PhD
Biomaterials/Biomechanics
& Preclinical Research
affiliate Firms
We work with other exceptional partners who can provide services to complement our expertise, and fulfill your needs.
MCRA is the leading privately held independent medical device and biologics Clinical Research Organization (CRO) and advisory firm. MCRA has offices in Washington, DC, Hartford, CT, and New York, NY, and serves more than 700 clients globally. Its core focus areas of therapeutic experience include orthopedics, spine, cardiovascular, diagnostic imaging, wound care, artificial intelligence, dental, general surgery, digital health, neurology, robotics, and in vitro diagnostic (IVD) devices. Dr. Bruder has coordinated with MCRA to provide Client Partners with both clinical and regulatory support in their pursuit of data generation and marketing approvals.
InnovAito is a pre-eminent patent monetization advisory service turning patents into revenues. Our proprietary approach to patent portfolio analysis unlocks tremendous value for our clients looking for competitiveness in the market. We are a think tank providing services for creation of highest quality patents from inventions, utilizing cutting edge artificial intelligence tool and machine learning at the patent claims level. We have an experienced team that has unlocked the revenue potential from multibillion dollar research budgets and worked with Fortune 500 companies, universities and SMEs. Dr. Bruder has partnered with Innovaito to provide clients with insights and action plans regarding their patent estate.
L.E.K. Consulting advises MedTech leaders on identifying new growth opportunities, enhancing profitability, and providing insight to manage all phases of transaction services. Their clients include eight of the 10 largest global MedTech companies, as well as emerging businesses. Their deep expertise across the life sciences, and healthcare spectrum enables them to understand how MedTech providers may be affected by hospital purchasing trends, payer reimbursement strategies, advances with companion diagnostics, and other market dynamics. Dr. Bruder is a member of the L.E.K. Life Science and MedTech Expert Network.
Wombat Capital is a New York City-based investment banking and strategic advisory firm. The company's business team, supported by its Advisory Board, the strategic and Financial network of its Directors and the close relationships developed with numerous companies, provide Wombat Capital with unparalleled access and insight. Dr. Bruder serves as Senior Advisor, Orthopedics and Regenerative Medicine.
